ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Cytomx Therapeutics (CTMX) Technical (Analysis) Reports Cytomx Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Cytomx Therapeutics (CTMX)

Technical Analysis Report for NASDAQ stock CTMX Cytomx Therapeutics. Dated: 23 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CTMX Cytomx Therapeutics then click here. or read Experts views on Cytomx Therapeutics or Forecast & share price targets of Cytomx Therapeutics

Cytomx Therapeutics Opened at 2.41 and Closed at: 2.32, which is -5.17% of previous session's close. It moved within a range of 2.31 and 2.42
The session was a Bearish session with an average volume of 4365900, which is 44% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.
  • The stock has fallen, and its long term trend is also negative and in a downtrend.

Support for tomorrow is 2.26 and resistance for tomorrow is 2.37
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.28, 2.24 resistance for tomorrow's hourly charts is 2.39, 2.46

10 Day SMA for Cytomx Therapeutics (CTMX) is 2.37 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Cytomx Therapeutics (CTMX) is 2.49 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Cytomx Therapeutics (CTMX) is 2.94 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 3.15 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Cytomx Therapeutics is 3.92 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Cytomx Therapeutics is at 2.49 and 200 DMA is at 3.92, while 50 DMA and 100 DMA are at 2.94 and 3.15 respectively

Cytomx Therapeutics (CTMX) moving average of 20 SMA is at 2.49 and 20 EMA is at 2.51

Cytomx Therapeutics (CTMX) moving average of 50 SMA is at 2.94 and 50 EMA is at 2.82

Cytomx Therapeutics (CTMX) moving average of 100 SMA is at 3.15 and 100 EMA is at 3.11

Cytomx Therapeutics (CTMX) moving average of 200 SMA is at 3.92 and 200 EMA is at 3.37

Regenxbio Inc has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Regenxbio Inc, about 3.17% more returns!

Cytomx Therapeutics has performed better than Pavmed Inc in short term. Holding Cytomx Therapeutics could be a better choice for now!

Acadia Pharmaceuticals has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Acadia Pharmaceuticals, about 9.85% more returns!

Adial Pharmaceuticals has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Adial Pharmaceuticals, about 10.78% more returns!

Anika Therapeutics has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Anika Therapeutics, about 17.33% more returns!

Catalyst Biosciences has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Catalyst Biosciences, about 1.98% more returns!

Cytomx Therapeutics has performed better than Corcept Therapeutics in short term. Holding Cytomx Therapeutics could be a better choice for now!

Delcath Systems has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Delcath Systems, about 4.96% more returns!

Dexcom Inc has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Dexcom Inc, about 3.67% more returns!

Establishment Labs has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Establishment Labs, about 11.39% more returns!

Fulgent Genetics has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Fulgent Genetics, about 3.64% more returns!

Hutchison China has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Hutchison China, about 15.38% more returns!

Orthopediatrics Corp has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 22.25% more returns!

Cytomx Therapeutics has performed better than Mesoblast in short term. Holding Cytomx Therapeutics could be a better choice for now!

Moderna Inc has performed better than Cytomx Therapeutics in short term. You could have earned much better returns by investing in Moderna Inc, about 15.18% more returns!

Cytomx Therapeutics Technical analysis of indicators

Price action analysis of Cytomx Therapeutics (CTMX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Cytomx Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Cytomx Therapeutics in short term but the buy signal is initial and weak.

Cytomx Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Cytomx Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Cytomx Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.37 and Cytomx Therapeutics CTMX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Cytomx Therapeutics CTMX stock. Volume based technical analysis of Cytomx Therapeutics CTMX stock is negative.

Cytomx Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock CTMX Cytomx Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CTMX Experts View which covers a lot of information including buying and selling signals

CTMX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cytomx Therapeutics or View Candle Stick Charts here

Chart Cytomx Therapeutics (CTMX)  Technical (Analysis) Reports Cytomx Therapeutics [

Videos related to: Cytomx Therapeutics (CTMX) Technical (Analysis) Reports Cytomx Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Cytomx Therapeutics (CTMX)  Technical (Analysis) Reports Cytomx Therapeutics [

 

Back to top